JPG 05/27/061

Overview of Health Science Overview of Health Science Policy Council ActivitiesPolicy Council Activities

May 27, 2006

JPG 05/27/062

OBJECTIVESOBJECTIVES•Describe Health Science Policy

Council•Discuss Issues and Deposition

JPG 05/27/063

OBJECTIVESOBJECTIVES•Describe Health Science

Policy Council

JPG 05/27/064

MISSIONMISSION

To advise the Society on important science, research and policy issues in pharmacoeconomics and outcomes research

JPG 05/27/065

MEMBERSHIPMEMBERSHIP• Lieven Annemans• Jon Clouse• Peter Davey• Michael Drummond• Robert Epstein• Jean Paul Gagnon*• Bryan Luce• Eva Lydick

• Joel Hay• William McGhan• Donald Patrick• Jim Smeeding• Sean Sullivan• George Torrance• Milton Weinstein• Marilyn Dix-Smith• ISPOR Scribe - Daniel Klim *Chairman

JPG 05/27/066

STRUCTURESTRUCTURE• Two weeks before meeting members or others submit new

issues to Committee Scribe• Council members identify and freely discuss issues submitted

at bi monthly meetings, lead assigned if topic approved• One month after meeting, lead constructs draft brief using

approved format• After Council discussion at subsequent meeting second draft

constructed• Final approval by Council and referral to Board for discussion

and action• If Board approves lead turns brief into Board Action Plan• Held six meetings in 2005/2006

JPG 05/27/067

BOARD FORMAT FOR BOARD FORMAT FOR APPROVED ISSUE APPROVED ISSUE

• Define issue • Describe specific tasks and/or products of action plan • Prioritize the initiatives’ work activities for current year• Provide clarity for operationalizing the work activities,

e.g., organization, timelines, and suggested work group members

• Suggest management arrangements for the issue, i.e., ideas from council champion on how the intended activity should be managed and monitored

• Outline resource requirements, i.e., council champion provides estimates on resources required

JPG 05/27/068

OBJECTIVESOBJECTIVES• Health Science Policy Council• Issues and Deposition

JPG 05/27/069

ACTIVITIESACTIVITIES• Issues Addressed Approved by the Council

and ISPOR Board, and Task Forces Formed: Continuous Quality Improvement for Cost-

Effective Health Care Research and Global Policy Lead – Bill McGhan

Good Research Practices Task Force on Economic Data Transferability

Lead – Mike Drummond

Drug Cost Good Research Practices Lead – Jim Smeeding Approved by Board

JPG 05/27/0610

ACTIVITIESACTIVITIES• Issues Addressed and Approved by the Council and

ISPOR Board: Where does Outcomes Research fit into Evidence-based

Health Care Decision-Making? Bryan Luce

Bridging the Health Measurement Gap? Mission Impossible?Donald Patrick, George Torrance, Eva Lydick (On Hold)

Probabilistic Analysis in Economic EvaluationMilt WeinsteinIssue Summary writtenFour or Five Authors will draft paper for ViH

JPG 05/27/0611

ACTIVITIESACTIVITIES• Issues Submitted But Have Not Received Final

Council Approval Explaining CEA to Decision-Makers and their Clients

Rob Epstein and Jean Paul Gagnon

How much More Qalys for the Qaly? Lieven Annemans

Balance between Efficiency and Equity in Health Care Priority Setting

Lieven Annemans

Role of Indirect Costs in CEA Joel Hay

JPG 05/27/0612

ACTIVITIESACTIVITIES• Issues Submitted But Have Not Received Final

Council Approval How can ISPOR react and support the Required Need

for Information Access under MMAJim Smeeding

Address three Major Science Policy Efforts: 1) Change Regulatory Approach to Communicating CE Evidence, 2) Partnering Between Industry and Private and Public Payers, and 3) Changing Public Payer to be Encourage and Permit CEA Evidence Submissions

Bryan Luce

JPG 05/27/0613

ACTIVITIESACTIVITIES• Issues Submitted but either sent back to

submitter or different judgment rendered: Four issues last year’s audience reviewed and

sent back to submitter with suggestions and comments, e.g., rewrite, join Task Force addressing this issue

Role of Probalistic MicrosimulationMike DrummondHandle as two position papers, e.g., Jaime Caro,

Pro and David Eddy Con for ViH

JPG 05/27/0614

NEW ISSUESNEW ISSUES• Anyone can submit issue to Science Policy

Council for development and discussion• Members are open to ideas• Each issue will be discussed and debated • Issue author will be recognized and

informed of issue status• Send issues to Jean Paul Gagnon at jean.

gagnon@sanofi-aventis.com

JPG 05/27/0615

FUTURE ACTIVITIESFUTURE ACTIVITIES

• Role in Policy Development• Identifying new relevant issues• Horizon scanning

JPG 05/27/0616

REACTION & REACTION & DISCUSSIONDISCUSSION

JPG 05/27/0617

Contact InformationContact Information

Jean Paul GagnonJean Paul Gagnonjean.gagnon@aventis.com 800-648-9499 Ext 6379 jean.gagnon@aventis.com 800-648-9499 Ext 6379

sanofi-aventissanofi-aventis